Skip to search formSkip to main contentSkip to account menu

triflusal

Known as: 2- (acetyloxy)-4-(trifluoromethyl)benzoic acid, 2-acetoxy-4-trifluoromethylbenzoic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
To the Editor: In “Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack,”1 the authors… 
Review
2009
Review
2009
D espite preventive measures and improved long-term prognosis, the prevalence of cardiovascular diseases in the majority of the… 
2002
2002
Background and Purpose— The fluorinated salicylate triflusal has been shown to have a neuroprotective effect after an excitotoxic… 
2001
2001
Background and Purpose— Nuclear factor-&khgr;B (NF-&khgr;B) and the signal transducer and activator of transcription 3 (STAT3… 
Highly Cited
1999
Highly Cited
1999
The therapeutic potential of drugs that block the induction of cyclooxygenase-2 has been emphasized. When two 4-trifluoromethyl… 
1991
1991
SummaryThe pharmacokinetic profile of triflusal (2-acetoxy-4-trifluoromethyl benzoic acid) and its main metabolite HTB (2-hydroxy… 
1990
1990
Triflusal pharmacokinetics were evaluated in 8 healthy subjects after a single 300 mg dose and after repeated doses of 300 mg… 
1986
1986
The effect of triflusal, acetylsalicylic acid (ASA), and of their principal metabolites 2-hydroxy-4-trifluoromethylbenzoic acid… 
1985
1985
The biological effects of a new antiplatelet agent, triflusal, were evaluated in patients with cardiac valvular prostheses. Each…